JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2022, Vol. 24 ›› Issue (3): 382-391.DOI: 10.3969/j.issn.1671-2587.2022.03.022
Previous Articles Next Articles
Received:
2022-04-08
Online:
2022-06-20
Published:
2022-06-22
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.lcsxyjy.com/EN/10.3969/j.issn.1671-2587.2022.03.022
[1] GHOSHAL K,BHATTACHARYYA M.Overview of platelet physiology:its hemostatic and nonhemostatic role in disease pathogenesis[J].Sci World J,2014,2014:781857. [2] LEFRANÇAIS E,ORTIZ-MUÑOZ G,CAUDRILLIER A,et al.The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors[J]. Nature,2017,544(7648):105-109. [3] GAERTNER F,MASSBERG S.Patrolling the vascular borders:platelets in immunity to infection and cancer[J]. Nat Rev Immunol,2019,19(12):747-760. [4] TAKEUCHI O,AKIRA S.Pattern recognition receptors and inflammation[J]. Cell,2010,140(6):805-820. [5] DIB P R B,QUIRINO-TEIXEIRA A C,MERIJ L B,et al. Innate immune receptors in platelets and platelet-leukocyte interactions[J].J Leukoc Biol,2020,108(4):1157-1182. [6] ZAKERI A,RUSSO M.Dual role of toll-like receptors in human and experimental asthma models[J].Front Immunol,2018,9:1027. [7] KOUPENOVA M,CLANCY L,CORKREY H A,et al.Circulating platelets as mediators of immunity,inflammation,and thrombosis[J].Circ Res,2018,122(2):337-351. [8] BERTHET J,DAMIEN P,HAMZEH-COGNASSE H,et al.Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion[J].Clin Immunol,2012,145(3):189-200. [9] KOESSLER J,NIKLAUS M,WEBER K,et al.The role of human platelet preparation for toll-like receptors 2 and 4 related platelet responsiveness[J].TH Open,2019,3(2):e94-e102. [10] EBERMEYER T,COGNASSE F,BERTHELOT P,et al.Platelet innate immune receptors and TLRs:a double-edged sword[J]. Int J Mol Sci,2021,22(15):7894. [11] RAYES J,WATSON S P,NIESWANDT B.Functional significance of the platelet immune receptors GPVI and CLEC-2[J]. J Clin Invest,2019,129(1):12-23. [12] SUNG P S,HUANG T F,HSIEH S L.Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A/TLR2[J]. Nat Commun,2019,10(1):2402. [13] SUNG P S,HSIEH S L.C-type lectins and extracellular vesicles in virus-induced NETosis[J].J Biomed Sci,2021,28(1):46. [14] XIN G,WEI Z L,JI C J,et al.Metformin uniquely prevents thrombosis by inhibiting platelet activation and mtDNA release[J]. Sci Rep,2016,6:36222. [15] HOTTZ E D,LOPES J F,FREITAS C,et al.Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation[J]. Blood,2013,122(20):3405-3414. [16] VOGEL S,MURTHY P,CUI X D,et al.TLR4-dependent upregulation of the platelet NLRP3 inflammasome promotes platelet aggregation in a murine model of hindlimb ischemia[J].Biochem Biophys Res Commun,2019,508(2):614-619. [17] KIM Y K,SHIN J S,NAHM M H.NOD-like receptors in infection,immunity,and diseases[J].Yonsei Med J,2016,57(1):5-14. [18] BROWN G T,NARAYANAN P,LI W,et al.Lipopolysaccharide stimulates platelets through an IL-1β autocrine loop[J]. J Immunol,2013,191(10):5196-5203. [19] DAVIZON-CASTILLO P,MCMAHON B,AGUILA S,et al.TNF-α-driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging[J]. Blood,2019,134(9):727-740. [20] POZNER R G,URE A E,JAQUENOD DE GIUSTI C,et al. Junín virus infection of human hematopoietic progenitors impairs in vitro proplatelet formation and platelet release via a bystander effect involving type I IFN signaling[J]. PLoS Pathog,2010,6(4):e1000847. [21] BORST O,MÜNZER P,GATIDIS S,et al.The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling[J]. Circ Res,2012,111(10):1297-1307. [22] CHATTERJEE M,BORST O,WALKER B,et al.Macrophage migration inhibitory factor limits activation-induced apoptosis of platelets via CXCR7-dependent Akt signaling[J].Circ Res,2014,115(11):939-949. [23] RATH D,CHATTERJEE M,HOLTKAMP A,et al.Evidence of an interaction between TGF-β1 and the SDF-1/CXCR4/CXCR7 axis in human platelets[J]. Thromb Res,2016,144:79-84. [24] CLEMETSON K J,CLEMETSON J M,PROUDFOOT A E,et al.Functional expression of CCR1,CCR3,CCR4,and CXCR4 chemokine receptors on human platelets[J]. Blood,2000,96(13):4046-4054. [25] HARGREAVES C E,ROSE-ZERILLI M J J,MACHADO L R,et al. Fcγ receptors:genetic variation,function,and disease[J].Immunol Rev,2015,268(1):6-24. [26] KERNTKE C,NIMMERJAHN F,BIBURGER M.There is (scientific) strength in numbers:a comprehensive quantitation of fc gamma receptor numbers on human and murine peripheral blood leukocytes[J]. Front Immunol,2020,11:118. [27] PATEL P,MICHAEL J V,NAIK U P,et al.Platelet FcγRⅡA in immunity and thrombosis:adaptive immunothrombosis[J].J Thromb Haemost,2021,19(5):1149-1160. [28] GIANAZZA E,BRIOSCHI M,BAETTA R,et al.Platelets in healthy and disease states:from biomarkers discovery to drug targets identification by proteomics[J]. Int J Mol Sci,2020,21(12):4541. [29] KOUPENOVA M,KEHREL B E,CORKREY H A,et al.Thrombosis and platelets:an update[J]. Eur Heart J,2017,38(11):785-791. [30] DEPPERMANN C,KUBES P.Platelets and infection[J]. Semin Immunol,2016,28(6):536-545. [31] SPAKOVA T,JANOCKOVA J,ROSOCHA J.Characterization and therapeutic use of extracellular vesicles derived from platelets[J].Int J Mol Sci,2021,22(18):9701. [32] CHEN F F,LIAO Z D,PENG D Y,et al.Role of platelet microparticles in blood diseases:future clinical perspectives[J]. Ann Clin Lab Sci,2019,49(2):161-170. [33] QU M Y,ZOU X J,FANG F,et al.Platelet-derived microparticles enhance megakaryocyte differentiation and platelet generation via miR-1915-3p[J].Nat Commun,2020,11(1):4964. [34] LAZAR S,GOLDFINGER L E.Platelets and extracellular vesicles and their cross talk with cancer[J]. Blood,2021,137(23):3192-3200. [35] PUHM F,FLAMAND L,BOILARD E.Platelet extracellular vesicles in COVID-19:potential markers and makers[J]. J Leukoc Biol,2022,111(1):63-74. [36] SCHROTTMAIER W C,MUSSBACHER M,SALZMANN M,et al.Platelet-leukocyte interplay during vascular disease[J]. Atherosclerosis,2020,307:109-120. [37] KAISER R,ESCAIG R,ERBER J,et al.Neutrophil-platelet interactions as novel treatment targets in cardiovascular disease[J].Front Cardiovasc Med,2022,8:824112. [38] CLARK S R,MA A C,TAVENER S A,et al.Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood[J]. Nat Med,2007,13(4):463-469. [39] VAJEN T,KOENEN R R,WERNER I,et al.Blocking CCL5-CXCL4 heteromerization preserves heart function after myocardial infarction by attenuating leukocyte recruitment and NETosis[J].Sci Rep,2018,8(1):10647. [40] PANICKER S R,MEHTA-D'SOUZA P,ZHANG N,et al.Circulating soluble P-selectin must dimerize to promote inflammation and coagulation in mice[J]. Blood,2017,130(2):181-191. [41] STARK K,PHILIPPI V,STOCKHAUSEN S,et al.Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice[J]. Blood,2016,128(20):2435-2449. [42] LOGUINOVA M,PINEGINA N,KOGAN V,et al.Monocytes of different subsets in complexes with platelets in patients with myocardial infarction[J]. Thromb Haemost,2018,118(11):1969-1981. [43] CARESTIA A,MENA H A,OLEXEN C M,et al. Platelets promote macrophage polarization toward pro-inflammatory phenotype and increase survival of septic mice[J]. Cell Rep,2019,28(4):896-908.e5. [44] FU G,DENG M H,NEAL M D,et al.Platelet-monocyte aggregates:understanding mechanisms and functions in Sepsis[J]. Shock,2021,55(2):156-166. [45] SHI G F,FIELD D J,KO K A,et al.Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection[J]. J Clin Invest,2014,124(2):543-552. [46] MAOUIA A,REBETZ J,KAPUR R,et al.The immune nature of platelets revisited[J].Transfus Med Rev,2020,34(4):209-220. [47] GUO L,SHEN S K,ROWLEY J W,et al.Platelet MHC class I mediates CD8+ T-cell suppression during Sepsis[J]. Blood,2021,138(5):401-416. [48] SPRAGUE D L,ELZEY B D,CRIST S A,et al.Platelet-mediated modulation of adaptive immunity:unique delivery of CD154 signal by platelet-derived membrane vesicles[J]. Blood,2008,111(10):5028-5036. [49] NISHAT S,WUESCHER L M,WORTH R G.Platelets enhance dendritic cell responses against Staphylococcus aureus through CD40-CD40L[J]. Infect Immun,2018,86(9):e00186-e00118. [50] LANGER H F,DAUB K,BRAUN G,et al.Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro[J]. Arterioscler Thromb Vasc Biol,2007,27(6):1463-1470. [51] WONG C H Y,JENNE C N,PETRI B,et al. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance[J]. Nat Immunol,2013,14(8):785-792. [52] HOTTZ E D,BOZZA F A,BOZZA P T.Platelets in immune response to virus and immunopathology of viral infections[J]. Front Med (Lausanne),2018,5:121. [53] LIPPI G,PLEBANI M,HENRY B M.Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections:a meta-analysis[J].Clin Chim Acta,2020,506:145-148. [54] ALTHAUS K,MARINI I,ZLAMAL J,et al.Antibody-induced procoagulant platelets in severe COVID-19 infection[J]. Blood,2021,137(8):1061-1071. [55] BONGIOVANNI D,KLUG M,LAZAREVA O,et al.SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype[J].Cell Death Dis,2021,12:50. [56] COMER S P,CULLIVAN S,SZKLANNA P B,et al.COVID-19 induces a hyperactive phenotype in circulating platelets[J].PLoS Biol,2021,19(2):e3001109. [57] ZAID Y,PUHM F,ALLAEYS I,et al.Platelets can associate with SARS-cov-2 RNA and are hyperactivated in COVID-19[J].Circ Res,2020,127(11):1404-1418. [58] CAPPELLANO G,RAINERI D,ROLLA R,et al.Circulating platelet-derived extracellular vesicles are a hallmark of sars-cov-2 infection[J]. Cells,2021,10(1):85. [59] HOTTZ E D,AZEVEDO-QUINTANILHA I G,PALHINHA L,et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19[J]. Blood,2020,136(11):1330-1341. [60] KOUPENOVA M,VITSEVA O,MACKAY C R,et al.Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis[J]. Blood,2014,124(5):791-802. [61] KOUPENOVA M,CORKREY H A,VITSEVA O,et al.The role of platelets in mediating a response to human influenza infection[J]. Nat Commun,2019,10(1):1780. [62] GARCIA C,COMPAGNON B,POËTTE M,et al. Platelet Versus Megakaryocyte: Who Is the Real Bandleader of Thromboinflammation in Sepsis?[J]. Cells,2022,11(9):1507. [63] GAERTNER F,MASSBERG S.Blood coagulation in immunothrombosis-at the frontline of intravascular immunity[J]. Semin Immunol,2016,28(6):561-569. [64] VERSCHOOR A,NEUENHAHN M,NAVARINI A A,et al.A platelet-mediated system for shuttling blood-borne bacteria to CD8α+ dendritic cells depends on glycoprotein GPIb and complement C3[J].Nat Immunol,2011,12(12):1194-1201. [65] ZUFFEREY A,SPECK E R,MACHLUS K R,et al.Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets[J]. Blood Adv,2017,1(20):1773-1785. [66] ELASKALANI O,FALASCA M,MORAN N,et al.The role of platelet-derived ADP and ATP in promoting pancreatic cancer cell survival and gemcitabine resistance[J]. Cancers,2017,9(10):142. [67] CHO M S,NOH K,HAEMMERLE M,et al.Role of ADP receptors on platelets in the growth of ovarian cancer[J]. Blood,2017,130(10):1235-1242. [68] HAEMMERLE M,STONE R L,MENTER D G,et al.The platelet lifeline to cancer:challenges and opportunities[J]. Cancer Cell,2018,33(6):965-983. [69] MICHAEL J V,WURTZEL J G T,MAO G F,et al. Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth[J]. Blood,2017,130(5):567-580. [70] XU X R,YOUSEF G M,NI H Y.Cancer and platelet crosstalk:opportunities and challenges for aspirin and other antiplatelet agents[J]. Blood,2018,131(16):1777-1789. [71] TAKEMOTO A,OKITAKA M,TAKAGI S,et al.A critical role of platelet TGF-β release in podoplanin-mediated tumour invasion and metastasis[J]. Sci Rep,2017,7:42186. [72] TANG M L,JIANG L,LIN Y Y,et al.Platelet microparticle-mediated transfer of miR-939 to epithelial ovarian cancer cells promotes epithelial to mesenchymal transition[J]. Oncotarget,2017,8(57):97464-97475. [73] HWANG B O,PARK S Y,CHO E S,et al.Platelet CLEC2-podoplanin axis as a promising target for oral cancer treatment[J]. Front Immunol,2021,12:807600. [74] MAMMADOVA-BACH E,ZIGRINO P,BRUCKER C,et al.Platelet integrin α 6 β 1 controls lung metastasis through direct binding to cancer cell-derived ADAM9[J]. JCI Insight,2016,1(14):e88245. [75] BOUCHARABA A,SERRE C M,GRÈS S,et al. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer[J]. J Clin Invest,2004,114(12):1714-1725. [76] MAURER S,FERRARI DE ANDRADE L.NK cell interaction with platelets and myeloid cells in the tumor milieu[J]. Front Immunol,2020,11:608849. [77] CLUXTON C D,SPILLANE C,O'TOOLE S A,et al. Suppression of Natural Killer cell NKG2D and CD226 anti-tumour cascades by platelet cloaked cancer cells:implications for the metastatic cascade[J]. PLoS One,2019,14(3):e0211538. [78] PLACKE T,ÖRGEL M,SCHALLER M,et al.Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells[J]. Cancer Res,2012,72(2):440-448. [79] BOUCHARD A,COLLIN B,GARRIDO C,et al.GARP:a key target to evaluate tumor immunosuppressive microenvironment[J]. Biology,2021,10(9):836. [80] ZIMMER N,KREBS F K,ZIMMER S,et al.Platelet-derived GARP induces peripheral regulatory T cells-potential impact on T cell suppression in patients with melanoma-associated thrombocytosis[J]. Cancers,2020,12(12):3653. [81] BURNOUF T,ELEMARY M,RADOSEVIC J,et al.Platelet transfusion in thrombocytopenic cancer patients:sometimes justified but likely insidious[J]. Transfus Apher Sci,2017,56(3):305-309. [82] WOOD B,PADULA M P,MARKS D C,et al.Cryopreservation alters the immune characteristics of platelets[J]. Transfusion,2021,61(12):3432-3442. |
[1] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(2): 249-252. |
[2] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 797-799. |
[3] | XU Qian-wen, XUE Lei, WANG Min, et al. Coagulation Disorder and Relevant Factors Analysis after Chimeric Antigen Receptor T Cell Therapy in Hematological Malignancies [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(3): 364-370. |
[4] | LIN Fang, ZHOU Mou, SHAN Gui-qiu, et al. Comparison of the Effect of Rehydration Solutions Prepared in Different Ingredients on Freeze-dried Platelet-rich Plasma Activation and Release of Growth Factors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 142-145. |
[5] | ZHAO Na-na, WANG Chao, JIN Hui-xin, et al. Investigation of CD36 Antigen Deficiency in Unpaid Blood Donors in Hefei [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 152-155. |
[6] | ZHOU Bo, TIAN Mao-sheng, MA Chen, et al. Establishment of HLA-A, B and HPA1-17 Genetic Database of Platelet Donors in Zibo Area [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 510-514. |
[7] | YANG Jin, HE An-hua, LI Ling-bo, et al. A Retrospective Analysis of Platelet Inhibition Rate in AA and ADP Pathways Detected by Thrombus Elastography [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(2): 118-121. |
[8] | ZHOU Ming, CHEN Yang, WANG Min, et al. Effect of Platelet Storage Lesion on The Clinical Efficacy of Transfusion [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(2): 129-133. |
[9] | HUANG Yan, LI Li, ZHANG Jue, et al. An Analysis of Risk Factors of Platelet Aggregation in The Elderly [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(2): 194-197. |
[10] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(2): 217-221. |
[11] | LI Juan, LUO Yi-qing, FANG Man, et al. The Influence of Platelets on Apoptosis of Lung Cancer Cells [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(1): 20-23. |
[12] | DIAO Rong-hua, WANG Ze-rong, WANG Shi-chun, et al. Study on the Qualities of Two Kinds Buffy-Coat-Collected Platelet Concentrates [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(1): 24-27. |
[13] | XIANG Ping, GAO Zhi-gang, LIU Jun. Analysis of the Data in Apheresis Platelets Collection in Tianjin District from 2014 to 2016 [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(1): 27-30. |
[14] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(1): 50-52. |
[15] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2018, 20(6): 604-607. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||